ONCOassist Deployed in The Clatterbridge Cancer Centre as Enterprise System

Portable Medical Technology LtdPortable Medical Technology and The Clatterbridge Cancer Centre NHS Foundation Trust have announced an enterprise agreement which will see ONCOassist, Portable Medical Technology's revolutionary CE approved software system being deployed as the main oncology decision support system used within Clatterbridge.

ONCOassist was launched in January of last year following extensive development involving oncologists, system developers and compliance personnel in Europe and the United States. Since launch ONCOassist has garnered growing acceptance amongst oncology professionals throughout the UK and Ireland. In August of this year, the platform was offered as an enterprise system. This enables individual trusts and institutions to integrate their guidelines and protocols and make them available throughout the trust in an easy to access and intuitive format across multiple mobile operating systems including iOS, Android and Windows.

The Clatterbridge Cancer Centre, based in Wirral, Merseyside, have been working closely with the ONCOassist team over the past twelve months and an enterprise agreement was the logical next step. "After many discussions with Clatterbridge we realised that, as access to the most up to date version of their protocol library was so important, developing a guidelines and protocols engine that allows for the easy integration and updating of trust specific content that can interact with the many CE approved tools already present on the platform would be of huge benefit," said Eoin O’Carroll of ONCOassist.

Thomas Poulter, Head of IM&T at The Clatterbridge Cancer Centre, said: "Having ONCOassist available in clinics and on the wards will save our clinicians time. The oncology nurses and clinicians will have access to all of the key oncology decision support information and tools they need. For example, our nurses often need to reference protocols or treatment algorithms when delivering chemotherapy treatment. ONCOassist makes it easy to do this."

Jo Upton, Skin Cancer Advanced Nurse Practitioner at The Clatterbridge Cancer Centre, said: "A cancer nurse's role is continually evolving to meet the needs of our patients. Important decisions relating to the management of treatment side-effects and the patient experience of their treatment are fast becoming central to the cancer nurse's role, especially in the outpatient setting. It is essential that vital information to aid decision-making in practice is quick and easy to access. I have found that the ONCOassist app provides easy access to formulas and decision-support information in my day-to-day job."

Kevin Bambury of ONCOassist said: "We are delighted to have The Clatterbridge Cancer Centre as the first NHS trust using our enterprise system. We look forward to working with them over the coming years as we continue to add features and functionality to the system."

About Portable Medical Technology
Portable Medical Technology Ltd develops quality, accredited and trusted apps for medical specialists to reduce medical errors, improve efficiencies and progress patient communication. We combine the essential tools specialists need into a single, easy-to-use smartphone and table application that are FDA and CE approved and provide the latest updated tools to support critical medical decision-making.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...